Constructing a multi-ancestry polygenic risk score for uterine fibroids using publicly available data highlights need for inclusive genetic research.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
Uterine leiomyomata, or fibroids, are common gynecological tumors causing pelvic and menstrual symptoms that can negatively affect quality of life and child-bearing desires. As fibroids grow, symptoms can intensify and lead to invasive treatments that are less likely to preserve fertility. Identifying individuals at highest risk for fibroids can aid in access to earlier diagnoses. Polygenic risk scores (PRS) quantify genetic risk to identify those at highest risk for disease. Utilizing the PRS software PRS-CSx and publicly available genome-wide association study (GWAS) summary statistics from FinnGen and Biobank Japan, we constructed a multi-ancestry (META) PRS for fibroids. We validated the META PRS in two cross-ancestry cohorts. In the cross-ancestry Electronic Medical Record and Genomics (eMERGE) Network cohort, the META PRS was significantly associated with fibroid status and exhibited 1.11 greater odds for fibroids per standard deviation increase in PRS (95% confidence interval [CI]: 1.05 - 1.17, p = 5.21x10-5). The META PRS was validated in two BioVU cohorts: one using ICD9/ICD10 codes and one requiring imaging confirmation of fibroid status. In the ICD cohort, a standard deviation increase in the META PRS increased the odds of fibroids by 1.23 (95% CI: 1.15 - 1.32, p = 9.68x10-9), while in the imaging cohort, the odds increased by 1.26 (95% CI: 1.18 - 1.35, p = 2.40x10-11). We subsequently constructed single ancestry PRS for FinnGen (European ancestry [EUR]) and Biobank Japan (East Asian ancestry [EAS]) using PRS-CS and discovered a nominally significant association in the eMERGE cohort within fibroids and EAS PRS but not EUR PRS (95% CI: 1.09 - 1.20, p = 1.64x10-7). These findings highlight the strong predictive power of multi-ancestry PRS over single ancestry PRS. This study underscores the necessity of diverse population inclusion in genetic research to ensure precision medicine benefits all individuals equitably.